prof. dr. H.J. (Hiddo) Lambers Heerspink

Clinical Pharmacologist

prof. dr. H.J. (Hiddo) Lambers Heerspink
Telephone:
E-mail:
h.j.lambers.heerspink umcg.nl

Research

Publications
  1. Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF

    Jhund, P. S., Solomon, S. D., Docherty, K. F., Heerspink, H. J. L., Anand, I. S., Böhm, M., Chopra, V., de Boer, R. A., Desai, A. S., Ge, J., Kitakaze, M., Merkely, B., O'Meara, E., Schou, M., Tereshchenko, S., Verma, S., Vinh, P. N., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Bengtsson, O., Langkilde, A. M., Sjöstrand, M. & McMurray, J. J. V., 2020, In : Circulation.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

    Oshima, M., Neuen, B. L., Li, J., Perkovic, V., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Levin, A., Mahaffey, K. W., De Nicola, L., Pollock, C., Rosenthal, N., Wheeler, D. C., Jardine, M. J. & Heerspink, H. J. L., Dec-2020, In : Journal of the American Society of Nephrology. 31, 12, p. 2925-2936 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure

    Boorsma, E. M., Beusekamp, J. C., ter Maaten, J. M., Figarska, S. M., Danser, A. H. J., van Veldhuisen, D. J., van Der Meer, P., Heerspink, H. J. L., Damman, K. & Voors, A. A., 16-Dec-2020, In : European Journal of Heart Failure. p. 1-10 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol

    BEAt-DKD Consortium, Gooding, K. M., Lienczewski, C., Papale, M., Koivuviita, N., Maziarz, M., Dutius Andersson, A-M., Sharma, K., Pontrelli, P., Garcia Hernandez, A., Bailey, J., Tobin, K., Saunavaara, V., Zetterqvist, A., Shelley, D., Teh, I., Ball, C., Puppala, S., Ibberson, M., Karihaloo, A., Metsarinne, K., Banks, R. E., Gilmour, P. S., Mansfield, M., Gilchrist, M., de Zeeuw, D., Heerspink, H. J. L., Nuutila, P., Kretzler, M., Welberry Smith, M., Gesualdo, L., Andress, D., Grenier, N., Shore, A. C., Gomez, M. F. & Sourbron, S., 29-Jun-2020, In : Bmc nephrology. 21, 1, 11 p., 242.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Individual atrasentan exposure is associated with long-term kidney and heart failure outcomes in patients with type 2 diabetes and chronic kidney disease

    Koomen, J. V., Stevens, J., Bakris, G., Correa-Rotter, R., Hou, F., Kitzman, D. W., Kohan, D. E., Makino, H., McMurray, J. J. V., Parving, H-H., Perkovic, V., Tobe, S. W., de Zeeuw, D. & L Heerspink, H. J., 18-Dec-2020, In : Clinical Pharmacology & Therapeutics. p. 1-22 22 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (325) »

Press / Media
  1. Geneesmiddel verlengt levensverwachting bij patiënten met nierfalen

    Hiddo Lambers Heerspink

    01/09/2020

    2 Media contributions

    Press/Media: Expert CommentPopular

  2. Pil die nieren spaart bij suikerziekte

    Hiddo Lambers Heerspink

    17/04/2019

    1 item of Media coverage, 4 Media contributions

    Press/Media: Public Engagement ActivitiesPopular

View all (6) »

Activities
  1. Asian-Australian Diabetes Meeting

    Hiddo Lambers Heerspink (Invited speaker)

    24-Aug-2019

    Activity: Participating in or organising an eventParticipation in conferenceAcademic

  2. European Association for the Study of Diabetes (EASD) Barcelona 2019

    Hiddo Lambers Heerspink (Invited speaker)

    17-Sep-2019

    Activity: Participating in or organising an eventParticipation in conferenceAcademic

  3. ASN Kidney week

    Hiddo Lambers Heerspink (Speaker)

    7-Nov-20199-Nov-2019

    Activity: Talk or presentationAcademic

View all (16) »

ID: 208085